Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

NASDAQ:IMMR - Nasdaq - US4525211078 - Common Stock - Currency: USD

8.475  -0.12 (-1.45%)

After market: 8.45 -0.03 (-0.29%)

Fundamental Rating

8

IMMR gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR gets an excellent profitability rating and is at the same time showing great financial health properties. IMMR may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make IMMR suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year IMMR was profitable.
IMMR had a negative operating cash flow in the past year.
IMMR had positive earnings in 4 of the past 5 years.
IMMR had a positive operating cash flow in 4 of the past 5 years.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

The Return On Assets of IMMR (36.36%) is better than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 44.16%, IMMR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
The Return On Invested Capital of IMMR (37.87%) is better than 96.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMMR is significantly below the industry average of 17.13%.
The last Return On Invested Capital (37.87%) for IMMR is above the 3 year average (9.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 36.36%
ROE 44.16%
ROIC 37.87%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMMR has a better Profit Margin (10.42%) than 87.10% of its industry peers.
In the last couple of years the Profit Margin of IMMR has grown nicely.
Looking at the Operating Margin, with a value of 12.02%, IMMR is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
IMMR's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.02%
PM (TTM) 10.42%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IMMR is creating value.
Compared to 1 year ago, IMMR has less shares outstanding
IMMR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 9.43 indicates that IMMR is not in any danger for bankruptcy at the moment.
IMMR's Altman-Z score of 9.43 is amongst the best of the industry. IMMR outperforms 90.32% of its industry peers.
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.43
ROIC/WACC4.14
WACC9.14%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.44 indicates that IMMR has no problem at all paying its short term obligations.
IMMR's Current ratio of 6.44 is amongst the best of the industry. IMMR outperforms 96.77% of its industry peers.
A Quick Ratio of 6.44 indicates that IMMR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.44, IMMR belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.44
Quick Ratio 6.44
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 138.10% over the past year.
IMMR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.60% yearly.
The Revenue has grown by 2512.31% in the past year. This is a very strong growth!
The Revenue for IMMR have been decreasing by -21.11% on average. This is quite bad
EPS 1Y (TTM)138.1%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%931.26%
Revenue 1Y (TTM)2512.31%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%6399.15%

3.2 Future

IMMR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.67% yearly.
IMMR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 265.82% yearly.
EPS Next Y75.07%
EPS Next 2Y57.24%
EPS Next 3Y13.67%
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y565.31%
Revenue Next 3Y265.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

IMMR is valuated cheaply with a Price/Earnings ratio of 6.78.
IMMR's Price/Earnings ratio is rather cheap when compared to the industry. IMMR is cheaper than 100.00% of the companies in the same industry.
IMMR is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 2.74, the valuation of IMMR can be described as very cheap.
100.00% of the companies in the same industry are more expensive than IMMR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.68. IMMR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.78
Fwd PE 2.74
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IMMR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IMMR is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.09
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMMR may justify a higher PE ratio.
A more expensive valuation may be justified as IMMR's earnings are expected to grow with 13.67% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y57.24%
EPS Next 3Y13.67%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.10%, IMMR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.03, IMMR pays a better dividend. On top of this IMMR pays more dividend than 87.10% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.1%

5.2 History

IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

IMMR pays out 4.53% of its income as dividend. This is a sustainable payout ratio.
DP4.53%
EPS Next 2Y57.24%
EPS Next 3Y13.67%
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M
IMMR Dividend Payout.IMMR Dividend Payout, showing the Payout Ratio.IMMR Dividend Payout.PayoutRetained Earnings

More info and screens

IMMERSION CORPORATION

NASDAQ:IMMR (2/21/2025, 8:00:01 PM)

After market: 8.45 -0.03 (-0.29%)

8.475

-0.12 (-1.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-22 2024-11-22/amc
Earnings (Next)05-06 2025-05-06
Inst Owners64.28%
Inst Owner Change-4.57%
Ins Owners5.09%
Ins Owner Change-0.55%
Market Cap273.57M
Analysts82.5
Price Target14.03 (65.55%)
Short Float %10.95%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 2.1%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP4.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-10 2025-01-10 (0.245)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)469.37%
Min Revenue beat(2)344.02%
Max Revenue beat(2)594.72%
Revenue beat(4)4
Avg Revenue beat(4)282.3%
Min Revenue beat(4)23.76%
Max Revenue beat(4)594.72%
Revenue beat(8)6
Avg Revenue beat(8)142.71%
Revenue beat(12)8
Avg Revenue beat(12)99.64%
Revenue beat(16)10
Avg Revenue beat(16)74.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)48.13%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1154.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.78
Fwd PE 2.74
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.36
EV/EBITDA 0.09
EPS(TTM)1.25
EY14.75%
EPS(NY)3.09
Fwd EY36.47%
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-1.74
OCFYN/A
SpS26.45
BVpS6.24
TBVpS6.24
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 36.36%
ROE 44.16%
ROCE 47.83%
ROIC 37.87%
ROICexc 229.01%
ROICexgc 229.01%
OM 12.02%
PM (TTM) 10.42%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover3.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.44
Quick Ratio 6.44
Altman-Z 9.43
F-Score4
WACC9.14%
ROIC/WACC4.14
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)138.1%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%931.26%
EPS Next Y75.07%
EPS Next 2Y57.24%
EPS Next 3Y13.67%
EPS Next 5YN/A
Revenue 1Y (TTM)2512.31%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%6399.15%
Revenue Next Year1039.86%
Revenue Next 2Y565.31%
Revenue Next 3Y265.82%
Revenue Next 5YN/A
EBIT growth 1Y449.81%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.62%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-244.13%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%